Innovation in Oligonucleotide Manufacturing Symposium 2025
April 29th, 9:30AM - 4:30PM BST
This symposium will bring together key stakeholders from across the sector to highlight the emerging process technologies in the field and explore how those processes are best developed and exploited to drive successful manufacturing at scale.
Scroll down to find out more about the day's agenda and speakers, to download a PDF version of the agenda, simply use the button below.
Schedule
Registration
Event welcome
Barrie Cassey, Technology Lead, Medicines Manufacturing Innovation Centre, CPI.
The future of manufacturing technology
9:30 - New Chemistry for Oligonucleotide Therapeutics - Tom Brown, Senior Emeritus Professor of Nucleic Acid Chemistry, University of Oxford.
10:00 - A new toolbox of options for advancing oligonucleotide production - Carina Strandh, Senior Global Product Manager, Cytiva.
10:25 - A Platform Approach to Enzymatic Oligonucleotide assembly and purification - Chris McKay, Scientific Leader, GSK.
Coffee break
The future of analytical and process development
11:20 - Mastering QC LC-MS in GMP Labs - Richard Blankley, Biopharma Application Specialist, Agilent.
11:45 - Acceleration of oligonucleotide process development via machine learning - Giacomo Padroni, Senior Chemist, CPI, and Charlie Phillips, Machine Learning Specialist, Intellegens.
12:10 - Optimisation of Oligonucleotide Processes Using In-Line PAT - Emily Robinson, Senior Process Engineer, AstraZeneca.
Panel discussion
Fast forward to the future: how can we industrialise these technologies now.
Lunch
The next wave of oligonucleotide therapeutics
14:00 - Novel linker chemistry for oligonucleotide conjugation - Sritama Bose, Head of Chemistry Research and Innovation, NATA.
14:25 - The Application of Nucleic Acid Therapeutics for Rare Diseases: the current status and future perspectives - Haiyan Zhou, Professor of Genetic Medicine, UCL.
14:50 - Expanding the aperture of therapeutic oligonucleotide modifications - Glenn Burley, Professor of Chemical Biology, University of Strathclyde.
Coffee break
Panel discussion
The next wave challenge - what do we need to implement to bring through new types of oligo therapeutics
Closing remarks
Claire MacLeod, CPI
Close, networking and leave
Speakers
Tom Brown
Emeritus Professor of Nucleic Acid Chemistry, University of Oxford
Sritama Bose
Head of Chemistry Research and Innovation, NATA MRC
Charlie Philips
Machine Learning Specialist, Intellegens
Haiyan Zhou
Professor of Genetic Medicine, Director of the MRC/NIHR Rare Disease Node on Nucleic Acid Therapy (UPNAT)
Giacomo Padroni
Senior Chemist, CPI Medicine Manufacturing Innovation Centre
Emily Robinson
Senior Chemical Engineer, AstraZeneca
Carina Strandh
Senior Global Product Manager, Cytiva
Chris Mackay
Scientific Leader – Process Engineering, GSK
Glenn Burley
Professor, Department of Pure and Applied Chemistry, University of Strathclyde
Barrie Cassey
Technology Director, CPI
Anna Watson
Associate Director – Processing Technologies, New Modalities, AstraZeneca
Mark Talford
Deputy Director – Medicines Manufacturing Future Medicines, Healthy Living and Agriculture Innovate UK
Richard Blankley
Biopharma Application Specialist, Agilent
Look forward to...
A packed schedule
Get ready for a day of talks, panel sessions, poster flashes, exhibitions and networking opportunities.
Food for thought
We have carefully selected our speakers with the goal of bringing thought-provoking, innovative ideas to the table.
Meaningful connections
Be ready to meet other brilliant minds, exchange ideas, network and lay the foundations for new, fruitful partnerships.